Embecta Corp.
NASDAQ:EMBCDrug Manufacturers - Specialty & Generic
+$0.02 today
- Market cap
- $345.06M
- Beta
- 0.81
- P/E (TTM)
- 1.6
- EPS (TTM)
- $1.92
- Dividend yield
- 14.79%
Volume 0.72M
Average 1.95M
EMBC EBITDA Margin
EBITDA as a percentage of revenue.
Embecta Corp.NASDAQ: EMBC
EBITDA Margin · Q2 FY2026 · quarter ended Mar 2026
EBITDA Margin narrows to 20.2%
EBITDA Margin was 20.2% in Q2 FY2026, down 8.4 pp from a year earlier. On a trailing-twelve-month basis it was 30.9%, up 11.2 pp year over year. Over 3 fiscal years it narrowed by 2.3 pp.
Context
- EBITDA Margin widened in 1 of the last 3 fiscal years.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 3 analysts of 27.1% for the fiscal year ending Sep 2026, down from 27.3% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- 20.2%-16.5 pp QoQ
- Last fiscal yearSep 2025
- 27.3%+9.6 pp YoY
- LTMMar 2026
- 30.9%+11.2 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -8.4 pp | -15.4 pp | -6.9 pp |
| 1 year | +9.6 pp | -0.1 pp | -9.7 pp |
| 3 years | -2.3 pp | -2.3 pp | +0.0 pp |
| 5 years | +5.5 pp | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 27.3%
- Year-over-year change
- +9.6pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | 27.3% | +9.6pp |
| FY2024 | 2024-09-30 | 17.7% | -4.2pp |
| FY2023 | 2023-09-30 | 21.9% | -7.7pp |
| FY2022 | 2022-09-30 | 29.6% | -16.1pp |
| FY2021 | 2021-09-30 | 45.8% | — |
EBITDA Margin vs competitors
How EMBC compares with its peers on the latest reported figures
- EMBC's LTM Mar 2026 EBITDA Margin of 30.9% is the highest of the 11 companies compared; the peer median is -33.5%.
- Its year-over-year change of +11.2 pp is the 4th highest of 11, against a peer median of -3.8 pp.
- Over three fiscal years its change of -2.3 pp compares with a peer median of -25.1 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 30.9% | +11.2 pp | -2.3 pp | |
| LTM Mar 2026 | 29.3% | -22.9 pp | -7.6 pp | |
| LTM Mar 2026 | 22.8% | +10.3 pp | +31.0 pp | |
| LTM Jun 2026 | 3.4% | +11.1 pp | +17.5 pp | |
| LTM Mar 2026 | -16.7% | -18.0 pp | -22.5 pp | |
| LTM Jun 2026 | -26.6% | +89.9 pp | -148.5 pp | |
| LTM Mar 2026 | -40.3% | -32.6 pp | -27.6 pp | |
| LTM Mar 2026 | -102.7% | -35.0 pp | -65.4 pp | |
| LTM Mar 2026 | -132.6% | -47.0 pp | — | |
| LTM Mar 2026 | -669.6% | +2109.2 pp | -668.6 pp | |
| LTM Mar 2026 | -4732.2% | +354.4 pp | — | |
| Peer median (excluding EMBC) | -33.5% | -3.8 pp | -25.1 pp | |
Competitors are the stored peer set for EMBC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Revenue | 1.17B | 1.13B | 1.12B | 1.12B | 1.08B |
| Cost of Revenue | 365M | 354.6M | 370.9M | 394.2M | 400.9M |
| Gross Profit | 800M | 774.9M | 749.9M | 728.9M | 679.5M |
| Gross Margin | 68.7% | 68.6% | 66.9% | 64.9% | 62.9% |
| Research & Development | 63M | 65M | 85.2M | 78.8M | 21.5M |
| Selling, General & Admin | 240.3M | 294.8M | 341.3M | 365.1M | 331.4M |
| Operating Expenses | 308M | 396.8M | 520.3M | 554.7M | 350.2M |
| Depreciation & Amortization | 38M | 31.7M | 32.7M | 42.5M | 51.1M |
| EBITDA | 533M | 334.5M | 245.4M | 199M | 294.7M |
| EBITDA Margin | 45.8% | 29.6% | 21.9% | 17.7% | 27.3% |
| Operating Income | 492M | 378.1M | 229.6M | 174.2M | 329.3M |
| Operating Margin | 42.2% | 33.5% | 20.5% | 15.5% | 30.5% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 46.2M | 107M | 112.3M | 107.3M |
| Other Income / Expenses | 3M | (121.5M) | (123.9M) | (130M) | (193M) |
| Income Before Tax | 495M | 256.6M | 105.7M | 44.2M | 136.3M |
| Pre-Tax Margin | 42.5% | 22.7% | 9.4% | 3.9% | 12.6% |
| Income Tax Expense | 80M | 33M | 35.3M | (34.1M) | 40.9M |
| Net Income | 414.8M | 223.6M | 70.4M | 78.3M | 95.4M |
| Net Margin | 35.6% | 19.8% | 6.3% | 7.0% | 8.8% |
| EPS (Basic) | 7.31 | 3.92 | 1.23 | 1.36 | 1.64 |
| EPS (Diluted) | 7.31 | 3.89 | 1.22 | 1.34 | 1.62 |
| Weighted Avg Shares | 56.8M | 57.06M | 57.24M | 58.43M | 58.31M |
| Weighted Avg Shares (Diluted) | 56.8M | 57.06M | 57.76M | 58.33M | 58.92M |
Embecta Corp.
NASDAQ:EMBC
Intrinsic Alpha fair value
Locked
Current Price
$6.09
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.